Organized around development of a fast, accurate, and simple testing system for improving worldwide health, GeneFluidics, Inc. has developed a technology platform capable of making highly manufacturable, cutting-edge electrochemical molecular analysis devices using integrated nanotechnology, plastic micro electromechanical systems(MEMS) and microfluidics. By integrating novel bionano and microfluidic technologies, the company's platform enables the conduct of complex tests -- normally performed only by skilled technicians in a laboratory -- to be performed by anyone, anywhere. Able to detect and analyze DNA/RNA, proteins and small molecules from raw samples without the use of PCR, the firm's systems produce highly accurate quantitative and qualitative results in minutes rather than hours or days and drastically reduce the cost of assays to a fraction of the price needed by competing systems.
